AzTrials
AzTrials

Quality Health CareNCT06653036

Dural Puncture Epidural Vs Standard Epidural Technique in Parturient Receiving Continuous Labour Epidural Infusion

A study testing Dural puncture epidural and Standard Epidural Technique in people with Quality Health Care, run by Aga Khan University at 1 site in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to evaluate the quality and safety of labor analgesia by comparing the use of Dural puncture epidural technique to Standard epidural technique while maintaining labor analgesia by means of continuous epidural infusion in parturient. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Quality Health Care
What is being tested?
Dural puncture epidural and Standard Epidural Technique
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
1 sitePakistan
Study dates
28 Nov 2024to 31 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Nulliparous / Multiparous women
  • Age >18 years
  • ASA 1 \& 2
  • Singleton vertex presentation
  • Gestational age 37-42 weeks
  • Parturient with established labor and pain score ≥ 3

Who cannot join

  • Major cardiac disease
  • History of chronic pain
  • Chronic opioid user
  • Platelet count < 70 x 109/L
  • spinal cord anomalies
  • Use of anticoagulants
Show all 9Show fewer
  • Allergic to local anesthetics
  • Patients with preeclampsia/ eclampsia
  • Known fetal anomalies

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Samina Ismail, MBBS, FCPS contact

+922134864331 ext. 4331

samina.ismail@aku.edu

Sehrish Khan, MBBS, FCPS contact

+923347126366

sehrish.khan@aku.edu

Pakistan1 site, 1 recruiting
  • Aga Khan University

    Karachi, Sindh

    Samina Ismail, MBBS, FCPS, +922134854331 ext. 4331, samina.ismail@aku.edu

    Recruiting

Other trials in Pakistan

About this study

Official title: Dural Puncture Epidural Vs Standard Epidural Technique in Parturient Receiving Continuous Labour Epidural Infusion: a Randomized Controlled Trial

The goal of this study is to evaluate the quality and safety of labor analgesia by comparing the use of Dural puncture epidural technique to Standard epidural technique while maintaining labor analgesia by means of continuous epidural infusion in parturient. The main questions it aims to answer are

  • Effectiveness and quality of labor analgesia
  • Frequency of catheter adjustments
  • Need for catheter replacements
  • Incidence of failed regional anesthesia requiring conversion to general anesthesia
Being tested
Dural puncture epidural, Standard Epidural Technique
Keywords
Quality Labor Analgesia, Maternal Adverse Events

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dural puncture epiduralProcedure or surgery

    The Dural puncture epidural technique is done by assessing the epidural space using the Touhy needle and puncturing the dura matter with a finer needle.

  • Standard Epidural TechniqueProcedure or surgery

    The Standard Epidural Technique is usually performed by identifying the epidural space using the loss of resistance technique and threading the epidural catheter in the epidural space for administration of analgesic drugs.

Study groups in NCT06653036
Study groupRoleWhat they receive
DPE groupActive comparatorParticipants who receive the dural puncture epidural (DPE) for labor analgesia.
Receives: Procedure: Dural puncture epidural
SET groupActive comparatorParticipants who will be receiving standard epidural technique (SET) for labor analgesia.
Receives: Procedure: Standard Epidural Technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Assessment

    Pain assessment by using numerical rating pain score and assessing sensory level. Numerical rating score: Pain Assessment: Numerical rating scale (NRS) 0 to 10. 0=no pain, 1-3 =mild pain, 4-7 =Moderate pain, 8-10= severe pain. Assessing sensory level: Testing will be done on specific dermatomes and will be compared bilaterally by either using one of these tests. 1. Light Touch Test: Dab a piece of cotton wool on an area of skin. 2. Temperature test: by using Ice on specific dermatomes and ask the patient if they feel cold sensation 3. Pinprick Test for pain sensation - Gently touch the skin with the pin ask the patient whether it feels sharp or blunt.

    Measured: At 30 minutes of initiation of infusion

  2. Need for catheter adjustment

    Persistence of either unilateral pain score (NRS) of >4, thirty minutes after 2 boluses of 10ml of 0.125% Bupivacaine

    Measured: At 30 minutes of initiation of infusion

Secondary outcomes (2)
  1. Patient Satisfaction

    Patient Satisfaction using a five-point satisfaction score as follows:

    Satisfied (score 1 to 3) ------------- Unsatisfied (score 4 to 5) -----------

    1. perfect: the patient did not experience any pain at all,
    2. very satisfied: helped relieve most of her pains,
    3. satisfied: the epidural procedure relieved major pains, but she still experienced minor pains,
    4. 4not satisfied: the epidural procedure helped only a bit a
    5. poor: the epidural procedure did not help at all. Scores from 1 to 3 were considered as the patient being satisfied with the labour epidural analgesia, and scores from 4 to 5 were regarded as the patient being unsatisfied with the labour epidural analgesia.

    Measured: At 30 minutes of initiation of infusion

  2. Assessment of the level of motor Block

    The level of the motor block will be assessed using the modified Bromage score. Where, 1 =unable to flex feet or knees, 2 =able to flex feet only, 3 =s able to flex knees, 4 = detectable weakness in hip flexion, 5 = no weakness with hip flexion

    Measured: At 30 minutes after the initiation of infusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2024
  2. Study start28 Nov 2024
  3. Primary completion30 Nov 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
38 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06653036
Sponsor's protocol ID
2024-10424-31009
Status last verified
Jan 2025
First submitted
26 Sep 2024
Last updated
30 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Dural puncture epidural and Standard Epidural Technique in people with Quality Health Care, run by Aga Khan University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Samina Ismail, MBBS, FCPS (+922134864331 ext. 4331, samina.ismail@aku.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Assessment (time frame: At 30 minutes of initiation of infusion). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in